Authors


Gunda Siska

Latest:

The Beauty of Vitamin A and Drug Spinoffs

The best natural and dietary supplements get turned into drugs. This is what happened to Vitamin A.


Muzi Hua, PharmD Candidate

Latest:

Study Examines Impact of Alcohol on Health, Drug Interactions in Older Women

Five risk factors increased the likelihood of problematic alcohol consumption in older women.


Dhiren Patel, PharmD, CDE, BC-ADM, BCACP

Latest:

Basal Insulin Therapy in Type 2 Diabetes Management: What the Pharmacist Should Know

Guidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.


Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief

Latest:

Time Horizon: An Early Career Perspective

The time frame concept is an underappreciated through line in most planning efforts.


Dale Christensen, PhD

Latest:

Pharmacists as Providers: The Road to Recognition in Washington State

National attention in the pharmacy press has focused recently on pharmacists being recognized as providers under federal health programs such as the Medication Modernization Act.



Todd A Brown

Latest:

Moving Health Care into the Future: Proposal for Pharmacist-led Refill Authorizations

Pharmacist-led refill authorizations are a practical solution to the nation’s health care crisis, helping to improve quality while reducing costs as well as saving physicians’ time.


Taylor A. VandenBerg

Latest:

Renal Cell Carcinoma is Treatable and Curable

Early diagnosis, surgery while cancer is confined to kidney are key, but pharmacological agents are used for Stage IV.



Tori A. Wilholt

Latest:

Easing the Minds of Parents 1 EpiPen at a Time

Allowing school access to epinephrine injectors improves patient care.


George DeMaagd, PharmD, BCPS

Latest:

Immune Checkpoint Inhibitor-Associated Nephritis: A Case of Nivolumab-Induced Acute Kidney Injury in a Patient with Urothelial Carcinoma

This case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.


Daniel C. Malone, PhD

Latest:

The Appropriateness of Use of 3 Classes of Psychotropic Medications in Children and Adolescents

For the majority of children and adolescents receiving a psychotropic medication there is a valid medical diagnosis.


Homa B. Dastani, PhD

Latest:

Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple Sclerosis

Fingolimod, a first-line, once-daily oral disease-modifying therapy for relapsing-remitting multiple sclerosis, has the lowest cost per relapse avoided compared with other first-line agents.


Shane P. Desselle, PhD

Latest:

Transformative Leadership Can and Should be Practiced by Everyone in the Pharmacy Organization

A transformational leader can make the difference between an efficient, profitable organization and one that is mired in mediocrity.


B. Douglas Hoey

Latest:

Rx for Medicare Transparency, Ending Retroactive Pharmacy Clawbacks

Improved transparency is needed to prevent clawback fees.


David Miller, CQE

Latest:

What Patients Should Know About Generic Drugs: A Resource Guide for Pharmacists

A wealth of resource is available to help pharmacists build public trust in the quality and efficacy of generic medications.


Clark Kucharski, BS

Latest:

E-Prescribing With Decision Support Is Associated With Improvements in Medication Adherence

This study evaluates whether provider adoption and use of formulary decision support for e-prescribing are directly associated with significant prescriber and patient behavior change.


Mary K. Gurney, PhD, RPh

Latest:

Patients learn what OTC items to have in their medicine cabinets, and how to dispose of old medications safely.



Nilanjana Dwibedi, MBA, MS

Latest:

Impact of Generic Drug Discount Programs on Managed Care Organizations

Generic drug discount programs, which differ across large chain pharmacies, may result in significant savings for managed care organizations.



Raymond A. Farkouh, PhD

Latest:

Cost-Effectiveness of Rasagiline Compared With First-Line Early Parkinson Disease Therapies

Examination of the cost-effectiveness of rasagiline versus other approved first-line Parkinson disease therapies indicated that rasagiline was either cost saving or cost-effective in all cases.


Sonali N. Shah, RPh

Latest:

Impact of Co-Payment Discounts on Antidepressant Medication Adherence and Costs

A unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.


Deepali Dixit, PharmD

Latest:

Managing Toxicities Associated With Immune Checkpoint Inhibitors

Although ICIs have demonstrated excellent efficacy, they also have been associated with unique irAEs.


Mayce N. Vinson, PharmD Candidate

Latest:

Prescriptive Authority for Pharmacists: Oral Contraceptives

More pharmacists are pushing for prescriptive power, leading to the enactment of new legislation in several states.


Craig L. Kephart

Latest:

Orphan Drugs: Small Markets, Big Opportunity

Orphan drug development has taken off as this segment of the industry has seen impressive growth. Here's an expert analysis of the orphan market by an industry leader outlining the challenges and opportunities.


Robert A. Fulcher, CAE

Latest:

The National Association of Specialty Pharmacy: Charting the Future of Specialty Pharmacy

NASP promotes collaboration among specialty pharmacy stakeholders, emphasizing the importance of education and advocacy.


Jeffrey A. Kyle, PharmD

Latest:

Acute Bacterial Rhinosinusitis: Knowing the Signs

A majority of sinus infections are viral in nature, and a thorough understanding of risk factors and symptoms will help clinicians know when antibiotics are needed.



Darya Inocencio, PharmD

Latest:

Encouraging Immunization Information System Use in Community Pharmacy Practice

Perhaps no sector has benefited more from technological advancement than health care, and within that world, community pharmacy is among the biggest beneficiaries.